Latest Morning Briefing Stories
The deal was struck in August and its liability clauses have not previously been reported, according to Reuters and CNBC. Other vaccine news is on the trials being run by Novavax and Sanofi, and more. And also: New York’s decision to review vaccines.
The contract guarantees the hiring of 160 more nurses, more protective gear and COVID hazard pay. In other news: California updates its “No Pharmacist Left Alone” law; Mayo Clinic Health System President Bobbie Gostout is retiring; Albertsons hires a former Amazon exec as its new senior VP of pharmacy and health; and more.
After stalling for months, Treasury Secretary Steven Mnuchin says coronavirus stimulus negotiations would resume as House Speaker Nancy Pelosi tells key House committee chairs to craft a new proposal that backs down on a previous $3.4-trillion ask. The new plan under discussion would cost closer to $2.4 trillion — which Republicans say is still too high.
A House report summing up a year-long investigation cites examples of medical mismanagement and records falsification.
President Donald Trump announced the final rule that clears the way for states to import cheaper medicines from Canada while outlining his “America First Health Plan” Thursday.
Researchers are urging hospitals to consider swapping out stainless steel surfaces for copper. COVID lives for several days on stainless steel but dies within hours on copper, studies show.
The slow rebound is causing financial concerns for hospitals. Also in the news: liability claims against home care nurses; medical deferrals for immigrants; COVID grants; Northwell Health; Teladoc; Amwell; and Community Health Systems.
With no clinical trials underway, a COVID-19 vaccine for children is unlikely before the fall of 2021. Other news stories report the latest on vaccine development by Sanofi, Merck and AstraZeneca.
The draft guidance is expected to be sent to hospitals this week. The government also wants hospitals to provide daily information on flu cases.
FDA Commissioner Stephen Hahn, NIH infectious disease chief Anthony Fauci and CDC Director Robert Redfield testified on the state of the coronavirus pandemic before a Senate panel Wednesday.
“I challenge that. You were not listening to what the director of the CDC said, that in New York, it’s about 22 percent. If you believe 22 percent is herd immunity, I believe you’re alone in that.” Dr. Anthony Fauci, the nation’s top infectious disease specialist, told Sen. Rand Paul (R-Ky.) during the Senate hearing. The two men have clashed before, but Wednesday’s exchange was particularly pointed.
Nearly all of the samples taken in the more recent months of the pandemic for the largest U.S. genetic study of the virus that causes COVID-19 contained a mutation that makes it easier to transmit, though not deadlier.
As shortages of N95 face masks persist, a study finds used ones can be sterilized with ultraviolet-C light. Another study finds 70% of Chinese-made N95s fail.
The Washington Post reported that the Pentagon chose to use money Congress allocated to “prevent, prepare for, and respond to coronavirus” to defense contractors for things like body armor and dress uniforms.
Draft guidelines submitted by the FDA to the White House propose standards for authorizing emergency use of a COVID-19 vaccine that match ones set for regular vaccine approval, The Washington Post reported. The agency’s move aims to reassure the public about vaccine safety and lowers the chances that one might be cleared before the Nov. 3 election.
Also in the news: the price of insulin versus other drugs; Legend Biotech; Keytruda; and Perdue Pharma CEO Craig Landau.
Missing from participation are the U.S., China and Russia. Other vaccine news including developments in Russia and China.
On Friday, the CDC website was updated to say that 6 feet of distance may not be enough to avoid airborne transmission of COVID-19. That guidance was removed on Monday. CDC officials say draft language was posted in error, but the misstep comes at a time when public confidence in the agency is taking a hit due to confusing messaging.
William Crews, a public affairs specialist for the National Institute of Allergy and Infectious Diseases, will leave the agency led by Dr. Anthony Fauci after the Daily Beast revealed that Crews is the managing editor of a conservative website where he authored many posts slamming Fauci, masks and other government COVID guidance.
On Saturday, 1,061,411 COVID-19 diagnostic tests were performed in the U.S., according to The COVID Tracking Project.